Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
about
S100A8 contributes to drug resistance by promoting autophagy in leukemia cellsGlobal Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsMolecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signallingMeta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemiaAnalyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays.High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway.Mass spectrometry in leukemia research and treatment.Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens.Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death.S100 Proteins in Acute Myeloid LeukemiaClinical Significance of Elevated S100A8 Expression in Breast Cancer Patients
P2860
Q28538712-BBFDCEFD-1D31-4F47-A228-A2557DB4E3EEQ33555287-745617FF-F3AC-4F36-BD8F-55D2B7FD2847Q34341915-6AA107FE-BE87-4154-BBBF-7614631627F1Q35653943-560D7E5B-D600-47D0-91FE-3C6AB37D58B4Q36276060-E287564C-4C95-4D79-8CA2-782C268AD11DQ36390565-93A9327D-7EB1-45DA-8DE2-343605CAD547Q37170575-DD3637E7-4F1C-4CA9-ABC1-5011D6336CB4Q38365432-F20C3C1F-6ED4-40E1-A21A-85D2FF9297C3Q41138910-100698AC-4B69-4691-8B9A-5F043F724461Q54327060-2E3D0A09-28E5-4CA5-A685-69749864D4B3Q55398393-B337ED86-AA29-4857-BB01-123C2150A512Q58576722-6DD744BE-CB20-42D3-8E7C-707B2A3E2667Q59130154-73B839AE-471A-4B9A-8757-FA0A4E988852
P2860
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@ast
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@en
type
label
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@ast
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@en
prefLabel
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@ast
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients
@en
P2093
A Bouamrani
S Berthier
P2860
P2888
P356
10.1038/LEU.2010.251
P577
2010-11-12T00:00:00Z
P5875
P6179
1033233286